These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25905546)

  • 1. Fecal Microbiota Transplantation: Just a Fancy Trend?
    Vandenplas Y; Pierard D; De Greef E
    J Pediatr Gastroenterol Nutr; 2015 Jul; 61(1):4-7. PubMed ID: 25905546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fecal microbiota transplantation: donor selection criteria, storage and preparation of biomaterials (review of current recommendations)].
    Iakupova AA; Abdulkhakov SR; Safin AG; Alieva IM; Oslopova JV; Abdulkhakov RA
    Ter Arkh; 2021 Feb; 93(2):215-221. PubMed ID: 36286640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A commentary on 'Alteration of the fecal microbiome in patients with cholecystectomy: potential relationship with postcholecystectomy diarrhea - before and after study'.
    Ye J; Hu Y; Li K
    Int J Surg; 2024 Feb; 110(2):1281-1282. PubMed ID: 37924491
    [No Abstract]   [Full Text] [Related]  

  • 4. We need more evidence about the risks and benefits of giving children faecal microbiota transplants.
    Abrahamsson T
    Acta Paediatr; 2024 Sep; 113(9):1987-1988. PubMed ID: 38926934
    [No Abstract]   [Full Text] [Related]  

  • 5. Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review.
    Rossen NG; MacDonald JK; de Vries EM; D'Haens GR; de Vos WM; Zoetendal EG; Ponsioen CY
    World J Gastroenterol; 2015 May; 21(17):5359-71. PubMed ID: 25954111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Intestinal Microbiome in Lipid and Glucose Metabolism in Diabetes Mellitus.
    van Olden C; Groen AK; Nieuwdorp M
    Clin Ther; 2015 Jun; 37(6):1172-7. PubMed ID: 25922340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook.
    Kelly CR; Kahn S; Kashyap P; Laine L; Rubin D; Atreja A; Moore T; Wu G
    Gastroenterology; 2015 Jul; 149(1):223-37. PubMed ID: 25982290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal Microbiota Transplantation for Clostridium difficile Infection: A Systematic Review.
    Drekonja D; Reich J; Gezahegn S; Greer N; Shaukat A; MacDonald R; Rutks I; Wilt TJ
    Ann Intern Med; 2015 May; 162(9):630-8. PubMed ID: 25938992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches to studying and manipulating the enteric microbiome to improve autism symptoms.
    Frye RE; Slattery J; MacFabe DF; Allen-Vercoe E; Parker W; Rodakis J; Adams JB; Krajmalnik-Brown R; Bolte E; Kahler S; Jennings J; James J; Cerniglia CE; Midtvedt T
    Microb Ecol Health Dis; 2015; 26():26878. PubMed ID: 25956237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gut microbiota and inflammatory bowel disease.
    Goto Y; Kurashima Y; Kiyono H
    Curr Opin Rheumatol; 2015 Jul; 27(4):388-96. PubMed ID: 26002031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal microbiota transplantation: what we know and what we need to know.
    Surawicz CM
    Ann Intern Med; 2015 May; 162(9):662-3. PubMed ID: 25938997
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of fecal microbial transplantations for disease states in Israel].
    Maharshak N
    Harefuah; 2015 Mar; 154(3):152-4, 213. PubMed ID: 25962241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Freeze-dried, Capsulized Fecal Microbiota Transplantation for Relapsing Clostridium difficile Infection.
    Tian H; Ding C; Gong J; Wei Y; McFarland LV; Li N
    J Clin Gastroenterol; 2015 Jul; 49(6):537-8. PubMed ID: 25955501
    [No Abstract]   [Full Text] [Related]  

  • 14. Host-microbiota interactions in the intestine.
    Elson CO; Alexander KL
    Dig Dis; 2015; 33(2):131-136. PubMed ID: 25925913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self or non-self? The multifaceted role of the microbiota in immune-mediated diseases.
    Kriegel MA
    Clin Immunol; 2015 Aug; 159(2):119-21. PubMed ID: 26003838
    [No Abstract]   [Full Text] [Related]  

  • 16. New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics.
    Patel R; DuPont HL
    Clin Infect Dis; 2015 May; 60 Suppl 2(Suppl 2):S108-21. PubMed ID: 25922396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Clostridium difficile infection in pediatric patients.
    Esposito S; Umbrello G; Castellazzi L; Principi N
    Expert Rev Gastroenterol Hepatol; 2015 Jun; 9(6):747-55. PubMed ID: 25912469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal microbiota transplant: benefits and risks.
    Weil AA; Hohmann EL
    Open Forum Infect Dis; 2015 Jan; 2(1):ofv005. PubMed ID: 26034756
    [No Abstract]   [Full Text] [Related]  

  • 19. The functional impact of the intestinal microbiome on mucosal immunity and systemic autoimmunity.
    Longman RS; Littman DR
    Curr Opin Rheumatol; 2015 Jul; 27(4):381-7. PubMed ID: 26002030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation.
    Kolho KL; Korpela K; Jaakkola T; Pichai MV; Zoetendal EG; Salonen A; de Vos WM
    Am J Gastroenterol; 2015 Jun; 110(6):921-30. PubMed ID: 25986361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.